VIENNA, Va., Jun 17, 2004 (BUSINESS WIRE) -- H-Quotient, Inc., (HQNTE), announced that it is in advanced negotiations to expand its medical products division through a stake in a software-controlled implantable monitoring cardiac device designed to enhance pacemakers by helping to prevent sudden cardiac death. The product is designed to detect arrhythmia, a disorder in the heart rate that leads to myocardial infarction (heart attack) that claims 300,000 lives each year. A patent application has been filed by the inventor with the U.S. Patent Office. FDA protocol development is ongoing and is expected to be completed within two months.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.